DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Abida W, Campbell D, Patnaik A. , et al.
Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses.
Ann Oncol 2019;
30 (October): v327-v328
DOI: 10.1093/annonc/mdz248.003 [Internet].
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.